Awarded
Ustekinumab 45 mg inyectable
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- ACCORD HEALTHCARE, S.L.U., AMGEN S.A., FRESENIUS KABI ESPAÑA, S.A., JANSSEN CILAG, S.A., LABORATORIOS STADA SL, Sandoz Farmaceutica
- Contract value
- €3,553,853
- Bids received
- 16
- Published
- 12 Jun 2026
- Awarded
- 9 Jul 2025
- Contract start
- 9 Jul 2025
- Contract end
- 10 Jul 2026estimated
- Region
- Toledo